Immune system – vaccine-level effect, no direct molecular target

The term "Immune system – vaccine-level effect, no direct molecular target" refers to the induction of a systemic adaptive immune response rather than the modulation of a specific molecular entity like a receptor or enzyme. This process involves the recognition of antigens by the innate immune system, followed by the activation and clonal expansion of B and T lymphocytes to establish long-term immunological memory (NIH, 2023). Unlike targeted therapies that bind to a single protein, vaccines leverage the entire immune repertoire to create a holistic defense against pathogens or malignant cells (CDC, 2024). This system-level effect is the cornerstone of preventative medicine for infectious diseases and is increasingly utilized in therapeutic cancer vaccines (WHO, 2023). Because this entry represents a complex physiological outcome rather than a discrete biochemical target, it is not classified as a standard therapeutic target in drug discovery frameworks.

Other names

VaccinationActive immunizationSystemic immune responseImmunological memory induction

Induction of a coordinated immune response involving antigen presentation, T-cell activation, and B-cell differentiation into plasma cells for antibody production and memory cell formation (StatPearls, 2024; CDC, 2024).